WO1995032671A1 - Method and device for providing vascular hemostasis - Google Patents
Method and device for providing vascular hemostasis Download PDFInfo
- Publication number
- WO1995032671A1 WO1995032671A1 PCT/US1995/006897 US9506897W WO9532671A1 WO 1995032671 A1 WO1995032671 A1 WO 1995032671A1 US 9506897 W US9506897 W US 9506897W WO 9532671 A1 WO9532671 A1 WO 9532671A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- puncture
- tissue tract
- range
- blood vessel
- over
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00641—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closing fistulae, e.g. anorectal fistulae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00663—Type of implements the implement being a suture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/0474—Knot pushers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
Definitions
- the present invention relates generally to methods and apparatus for occluding vascular punctures. More particularly, the present invention relates to a device which may be introduced through a tissue tract to apply pressure directly over the adventitial surface of a blood vessel wall in the region of the vascular puncture.
- Coronary and other vascular catheters are usually introduced to a patient's vasculature by the Seldinger technique.
- a small gauge needle is introduced through the skin to a target blood vessel, such as the femoral artery in the region of the patient's groin for coronary procedures.
- the needle forms a puncture through the blood vessel wall at the distal end of a tract through the overlying tissue.
- a guide wire is then introduced through the needle, and the needle withdrawn over the guide wire.
- An introducer sheath is next introduced over the guide wire, and the sheath and guide wire are left in place to provide access during subsequent procedure(s) .
- exemplary procedures include diagnostic procedures such as angiography, ultrasonic imaging, and the like, and interventional procedures, such as angioplasty, atherectomy, stent placement, laser ablation, graft placement, and the like.
- interventional procedures such as angioplasty, atherectomy, stent placement, laser ablation, graft placement, and the like.
- the most common technique for providing "hemostasis” is to apply pressure on the patient's skin in the region of the tissue tract and vascular puncture. Pressure can be applied manually or through the use of mechanical clamps and other pressure-applying devices. While effective in most cases, the application of external pressure to the patient's skin suffers from a number of disadvantages. When applied manually, the procedure is time-consuming, frequently requiring the presence of a nurse for one-half hour or more. For both manual and mechanical pressure application, the procedure is uncomfortable for the patient and frequently requires the administration of analgesics to be tolerable. Moreover, the application of excessive pressure can sometimes occlude the underlying artery, resulting in ischemia and/or thrombosis.
- a suture applying device is introduced through the tissue tract with its distal end located at the vascular puncture.
- One or more needles on the device are used to draw a suture through the blood vessel wall on opposite sides of the puncture, and the suture is secured directly over the adventitial surface of the blood vessel wall to provide highly reliable closure.
- a significant improvement over the use of manual pressure, clamps, and collagen plugs in rare cases there can still be blood leakage through the sutured vascular puncture, particularly when the patient has been heavily treated with anticoagulants.
- a device and method for placing an inflatable balloon over a vascular puncture site and applying laser energy to thermally weld the artery are described in U.S. Patent No. 4,929,246.
- Hemostatic closure devices which place a collagen plug and polymer anchor on the adventitial and luminal surfaces of a blood vessel at a puncture site are described in a brochure of the Kensey Nash Corporation entitled The Hemostatic Puncture Close Device (undated) .
- Vessel closure devices employing collagen and other plugs are described in U.S. Patent Nos. 5,222,974; 5,192,302; 5,108,421; 5,061,274; 5,021,059; 4,890,612; and 4,744,364.
- a three part hemostasis device for introducing a collagen plug over a vascular puncture site is described in Merino et al., A Vascular Hemostasis Device for Percutaneous Interventional Procedures , Mount Sinai Medical Center, New York, New York (undated) and Ernst et al., Immediate Sealing of Arterial Puncture Sites after Catheterization and PTCA Using a Vascular Hemostasis Device With Collagen: An International Registry, (undated) .
- Knot pushers, appliers, and related suturing devices are described in U.S. Patent Nos. 5,176,691; 5,201,744; 5,250,054; 4,803,984; 2,595,086; 2,131,321; 1,940,351; and 1,574,362. Co-pending applications having Serial Nos.
- the present invention provides methods and devices for engaging and applying pressure directly to the adventitial surface of a blood vessel wall in the region of a vascular puncture in order to effect or enhance hemostasis.
- the adventitial surface is the outer most covering of the blood vessel, also referred to as the tunica adventitia in the case of arteries.
- direct application of pressure it is meant that a surface or other pressure-applying means is contacted directly against the adventitial surface at the distal end of a percutaneous tissue tract which has been formed as part of the vascular puncture.
- most prior methods for effecting hemostasis relied on the indirect application of pressure to the puncture site by manually pressing or clamping the patient's skin over the vascular puncture.
- the present invention preferably relies on contacting an annular surface, usually a flat or slightly convex surface having a circular or elliptical periphery, over suture and/or a guidewire extending from the puncture through the tissue tract and directly against the adventitial surface of the blood vessel wall.
- the surface can by itself provide hemostasis sufficient to permit clotting and the initial stages of healing of the vascular puncture.
- the annular surface can be introduced over the guide wire which is left in place until the patient's condition appears to have stabilized sufficiently to withdraw the guide wire and subsequently the annular surface. It has been found that the direct application of pressure with the annular surface allows clotting and provides hemostasis even without the application of heat, as proposed in U.S. Patent 4,929,246.
- the method of the present invention is used in combination with other procedures for providing hemostasis.
- the method provides for contacting the annular surface against a vascular puncture site which has been previously sutured to effect primary closure.
- the annular surface will be introduced over the free ends of the suture in order to inhibit or stop residual bleeding which might occur in rare cases even after the primary suture loop(s) have been tied and tightened.
- the annular surface can also be used in conjunction with the application of tissue glues, such as those including fibrinogen, thrombin, and the like. In all cases, it is possible to secure the surface within the tissue tract so that manual retention of the surface is not necessary.
- the method of the present invention will apply sufficient force over a predetermined area (i.e., pressure) to effect hemostasis at the vascular puncture site.
- a force in the range from about 5 g to 50 g will be applied over an area in the range from about 6 mm 2 to 30 mm 2 .
- the resulting pressures are typically applied for a period from about 10 minutes to 24 hours in order to effect hemostasis.
- a device according to the present invention comprises a shaft having a proximal end, a distal end, and an annular surface at its distal end. The surface will generally have a circular or elliptical periphery and will span an area in the range from 6 mm 2 to 30 mm 2 .
- the surface will be oriented at an angle from about 30° to 60° relative to the axis of the shaft. It will be appreciated that the tissue tract into the femoral artery formed by the Seldinger technique typically lies at an angle from about 30° to 60° relative to the arterial axis.
- the angle of the annular surface relative to the shaft is thus selected to permit introduction of the shaft through the tissue tract and positioning of the annular surface so that it lies flat over the adventitial surface of the blood vessel wall.
- an axial channel or lumen is provided in the shaft to receive the suture or guide wire and facilitate anchoring the suture or guidewire to the proximal end of the device to hold the device in place.
- a pair of circumferentially spaced-apart apertures or slots are formed at the edges of the annular surface or a proximal surface to receive free suture ends for use of the device on punctures which have been previously sutured.
- the apertures or slots permit the device to be used as a knot pusher for advancing and tightening knots which are tied outside the tissue tract.
- the shaft is cylinder and the annular surface is formed as a planar section through the cylinder at the preferred angle.
- the cylinder typically has a diameter from 2 mm to 10 mm and a length from about 7 cm to 12 cm.
- Fig. 1 is a perspective view of a blood vessel puncture occlusion device constructed in accordance with the principles of the present invention.
- Fig. 2 is a perspective view of the device of Fig. 1, taken from a bottom perspective.
- Fig. 3 is a top plan view of the device of Fig. 1.
- Fig. 4 is a side cross-sectional view of the device of Fig. 2.
- Fig. 5 illustrates a simplified device constructed in accordance with the principles of the present invention.
- Fig. 6 is a right end view of the device of Fig. 5.
- Fig. 7 is a perspective view of an alternative embodiment of the blood vessel puncture occlusion device of the present invention.
- Fig. 8 is a distal end view of the device of Fig. 7.
- Fig. 9 is a proximal end view of the device of Fig. 7.
- Fig. 10 is a side view of the device of Fig. 7 shown in partial section.
- Fig. 11 is a perspective view of another alternative embodiment of the blood vessel puncture occlusion device of the present invention.
- Fig. 12 is a side view of the device of Fig. 11 shown in partial section.
- Fig. 13 illustrates an introducer sheath and guide wire which have been placed through a vascular puncture in a blood vessel by the Seldinger technique.
- Fig. 14 illustrates the vascular puncture as in
- Fig. 15 illustrates a first method for providing hemostasis according to the present invention where pressure is applied directly in the absence of suture and a guide wire.
- Fig. 16 illustrates a second method for providing hemostasis according to the present invention where pressure is applied over a guide wire.
- Figs. 17 and 18 illustrate a third method for providing hemostasis according to the present invention, where a suture loop is first formed and closed, and pressure applied over free ends of the suture extending from the vascular puncture site.
- the device 10 comprises an elongate shaft 12 having a proximal end 14 and an annular surface 16 at its distal end 18.
- An aperture or port 20 is formed generally in the center of the annular surface 16 and extends to an opening 22 (Figs. 3 and 4) at the distal end of an axial channel 24.
- a pair of circumferentially spaced-apart apertures or slots 26 are formed on opposite sides of the annular surface 16.
- An O-ring 28 circumscribes the shaft 12 near its proximal end 14 and serves to clamp or anchor suture or a guide wire which is brought through slots 26 or opening 22 into channel 24, as will be described in more detail hereinafter.
- the annular surface 16 in the exemplary device 10 comprises a planar section of a cylindrical body which forms the shaft 12.
- the surface 16 is generally flat and formed at an angle in the range from 30° to 60° relative to the axis of shaft 12, preferably from 40° to 50°.
- the annular surface 16 need not be completely flat, and may in some cases be slightly convex in order to focus or center applied pressure to the puncture site in the blood vessel wall.
- the annular surface 16 will have an area in the range from 6 mm 2 to 30 mm 2 , preferably from 15 mm 2 to 25 mm 2 .
- the center of the surface will typically be raised from the edge by distance in the range from about 0.1 mm to 1 mm.
- the length of the shaft 12 will typically be in the range from 7 cm to 12 cm.
- the cylindrical shaft 12 will usually have a uniformed diameter in the range from 2 mm to 10 mm, preferably from 6 mm to 8 mm.
- the occlusive surface 16 which results is thus an elliptical surface which is a section through the cylindrical shaft.
- the surface 16 may be compliant or non-compliant. By “non-compliant” it is meant that the surface 16 will be able to apply pressure to the vascular puncture site without significant yield. In the embodiment of Figs. 1-4, the surface 16 is non-compliant since it is a terminal surface of solid cylindrical shaft 12, typically composed of a rigid material, such as polycarbonate, glass, ceramic, metal, or the like. In other cases, it would be possible to form the surface 16 from a compliant material, such as an elastomeric polymer, e.g., silicone rubber. A variety of mechanisms could be provided for securing suture or a guide wire to the proximal end of the device 10.
- suitable mechanisms include clips, adhesives, tapes, cleats, slits, latches, hooks, and other structures for securing or tying suture or a guide wire to the proximal end.
- Device 30 is simplified (in comparison to the device of Figs. 1-4) and comprises an elongate rod 32 having a finger-grasping means 34 at its proximal end and a pressure- applying surface 36 at its distal end.
- the surface is a circular disc, typically formed from metal, plastic, glass, ceramic, or the like, having a diameter in the range from 2 mm to 10 mm, preferably from 6 mm to 8 mm.
- the surface 36 will be oriented at an angle ⁇ in the range from 30° to 60°, preferably from 40° to 50°.
- the length of rod 32 will typically be in the range from 7 cm to 12 cm, preferably from 8 cm to 10 cm.
- FIG. 7-10 An alternative embodiment 100 of a blood vessel puncture occlusion device of the present invention is illustrated in Figs. 7-10.
- the device 100 is intended for applying pressure against the adventitial surface of a blood vessel wall surrounding a puncture site and will not be suitable for knot advancement.
- the device 100 comprises a shaft 102 having the dimensions generally set forth above for the embodiment of Figs. 1-4, but will be composed of a relative soft, compliant material, such as silicone rubber.
- An opening or gap 104 will be formed in the distal surface 106 which engages the adventitial surface of the blood vessel wall.
- the opening has a width and depth sufficient to receive a knot in suture, typically from 1 mm to 3 mm and 1 mm to 5 mm, respectively, and permits additional tightening or cinching on a knot in suture, where the knot is received in the opening 104 and suture passes proximally through axial lumen 108.
- the ability to tighten the suture is particularly valuable when the knot has not been tied closely over the adventitial surface, i.e., an "air knot" has been inadvertently tied.
- the device 100 further includes slots 110 formed at the proximal end. The slots 110 facilitate tying of suture to the device to hold the device in place for extended time periods.
- the device 100 will also be suitable for application of force to provide hemostasis, even when suture has not been previously placed.
- the device 100 can be introduced over a guidewire which passes through the tissue tract and into the blood vessel or lumen, and pressure applied until hemostasis is achieved or another procedure initiated to achieve hemostasis.
- Another alternative embodiment 200 of the blood vessel puncture occlusion device of the present invention is illustrated in Figs. 11 and 12.
- the device 200 has a first end 202 intended for applying pressure over a vascular penetration to achieve hemostasis, as generally described for previous embodiments, and a second end 204 intended for advancing knots or knot throws, also as generally described for previous embodiments.
- the device 200 includes a cylindrical shaft or body 206 which is typically formed from a relative hard or rigid material, such as polycarbonate.
- a soft tip 208 is at the first end 202 and defines a compliant surface 210 for engaging the adventitial surface of the blood vessel.
- An opening or gap 212 is formed in the soft tip 208 and is connected to an axial channel 214 in the shaft 206, and an O-ring 216 is provided to anchor the device in place. Suture and/or a guidewire can be received through the opening 212 and into the channel 214 to achieve or enhance hemostasis as generally described above for the other embodiments.
- an introducer sheath 40 and guide wire 42 may be introduced to a blood vessel lumen BV through a tissue tract TT.
- the tissue tract TT extends percutaneously from the outer surface of the patient's skin S to a vascular puncture P formed through the blood vessel wall.
- the adventitial surface A is the exterior surface of the blood vessel wall.
- the introducer sheath 40 and guide wire 42 may be used in a variety of conventional diagnostic and interventional procedures in a manner well known in the art.
- the introducer sheath 40 will be partially or totally withdrawn, as illustrated in Fig. 14, leaving the tissue tract TT and puncture P open. It will be appreciated that the open tissue tract TT and puncture P can result in substantial blood loss after the introducer 40 has been withdrawn.
- blood loss through the puncture P and tissue tract TT can be staunched by removing with guide wire 42 and introducing the device 10 through the tissue tract so that the annular surface 16 directly engages the adventitial wall A over the puncture P, as illustrated in Fig. 15.
- the non-compliant surface will be engaged against the adventitial surface A with a force typically in the range from 5 g to 50 g, more typically from 5 g to 25 g. Pressure may be maintained for time sufficient to permit initial blood coagulation and healing of the puncture site P.
- the guide wire 42 may be left in place with the device 10 introduced thereover.
- the guide wire 42 will pass through aperture 20 in the non- compliant surface 16, and upward through the channel 24.
- the applied force and treatment time will generally be as described above.
- the device 10 may optionally be held in place by securing the guide wire with 0-ring 28, or with any other securing structure which may be provided on the device 10.
- the guide wire 10 has a very small diameter, typically being about 0.038 inches, and that hemostasis and clotting may initiate around the guide wire, with the guide wire 42 being subsequently withdrawn. In some case, the guide wire may be withdrawn with the device 10 remaining in place with non-compliant surface 16 engaged against the puncture P.
- a primary closure of puncture P will be effected by passing a suture loop L through the blood vessel wall on opposite side of the puncture.
- the suture loop L is then tied-off, or otherwise secured, and the knot or other fastening structure passed down through the tissue tract to lie over the adventitial surface A.
- Methods and devices for forming such suture loops are well described in co-pending applications Serial No. 07/989,611, Serial No. 08/148,089, and PCT/US93/11864, the disclosures of which are incorporated herein by reference.
- a first knot K may be pushed down the tissue tract TT using a rod or other conventional knot pusher.
- a particularly useful not pusher is described in copending application serial no. 08/ 252,310 , (attorney docket no. 15508-14, the disclosure of which is incorporated here in by reference) .
- Additional knot throws may be advanced using the device 10 by passing each of the two free suture ends through one of the slots 26 and outward through the channel 24 (Figs. 1-4) . The additional knot throws are thus advanced and tightened by tensioning the free suture ends and pushing the non-compliant surface 16 against the suture loop.
- the non- compliant surface 16 will at the same time apply pressure over the puncture in adventitial wall A to inhibit hemostasis.
- Advice 10 may be secured by fastening the free suture ends using O-ring 28, with the device 10 being left in place for a desired amount of time to promote hemostasis and initial clot formation.
- the device 10 can be used wherever it is desired to apply direct pressure to a vascular puncture through a tissue tract. It can be used, for example, if other methods for closing a vascular puncture have failed.
- the device can also be used in conjunction with the application of "tissue glues" at the site of the vascular puncture.
- Suitable tissue glues will comprise one or more components of the clotting cascade, typically comprising at least fibrinogen or thrombin, and more typically comprising both fibrinogen and thrombin.
- Suitable tissue glues are well described in the patent and medical literature. See, for example, U.S. Patent Nos. 4,928,603; 4,909,251; 4,427,650, the disclosures are incorporated herein by reference.
- the tissue glues may be introduced prior to application of pressure using the device 10 or maybe coated on the non-compliant surface and delivered to the site of vascular puncture using the device 10.
Abstract
A device (10) for providing or enhancing hemostasis at a vascular puncture site disposed at the distal end of a tissue tract, comprises a shaft (12) having a non-compliant surface (16) at its distal end. The non-compliant surface (16) is oriented at an angle which allows it to lie flat over tissue punctures when the tissue tract is oriented obliquely, e.g., as the result of the Seldinger catheter introduction technique. The device may be used by itself or in combination with suturing of the vascular puncture, where the device enhances hemostasis and prevents blood leakage through the primary suture closure.
Description
METHOD AND DEVICE FOR PROVIDING VASCULAR HEMOSTASIS
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to methods and apparatus for occluding vascular punctures. More particularly, the present invention relates to a device which may be introduced through a tissue tract to apply pressure directly over the adventitial surface of a blood vessel wall in the region of the vascular puncture. Coronary and other vascular catheters are usually introduced to a patient's vasculature by the Seldinger technique. A small gauge needle is introduced through the skin to a target blood vessel, such as the femoral artery in the region of the patient's groin for coronary procedures. The needle forms a puncture through the blood vessel wall at the distal end of a tract through the overlying tissue. A guide wire is then introduced through the needle, and the needle withdrawn over the guide wire. An introducer sheath is next introduced over the guide wire, and the sheath and guide wire are left in place to provide access during subsequent procedure(s) . Exemplary procedures include diagnostic procedures such as angiography, ultrasonic imaging, and the like, and interventional procedures, such as angioplasty, atherectomy, stent placement, laser ablation, graft placement, and the like. After the procedures are completed, the catheters, guide wire, and introducer sheath are removed, and it is necessary to close the vascular puncture to provide hemostasis (i.e., stop blood loss) and allow healing.
The most common technique for providing "hemostasis" is to apply pressure on the patient's skin in the region of the tissue tract and vascular puncture. Pressure can be applied manually or through the use of mechanical clamps and other pressure-applying devices. While effective in most
cases, the application of external pressure to the patient's skin suffers from a number of disadvantages. When applied manually, the procedure is time-consuming, frequently requiring the presence of a nurse for one-half hour or more. For both manual and mechanical pressure application, the procedure is uncomfortable for the patient and frequently requires the administration of analgesics to be tolerable. Moreover, the application of excessive pressure can sometimes occlude the underlying artery, resulting in ischemia and/or thrombosis. Even after hemostasis has apparently been achieved, the patient must remain still and under observation for hours to assure that the bleeding remains stopped. Renewed bleeding through the tissue tract is not uncommon and can result in hematoma, pseudoaneurisms, and arteriovenous fistulas. Such complications may require blood transfusion, surgical intervention, or other corrective procedures. The risk of these complications increases with the use of larger sheath sizes, which are frequently necessary in interventional procedures, and when the patient is anticoagulated. To overcome these problems, several groups have proposed the use of bioabsorbable plugs and fasteners to stop bleeding. Generally, these approaches rely on placing a bioabsorbable material, such as collagen, at the adventitial blood vessel wall over the puncture site. While potentially effective, the use of collagen plugs also suffers from certain problems. It can be difficult to properly locate the plug at the interface between the tissue and adventitial surface of the blood vessel. To help in such positioning, some systems rely on placement of a fastener within the blood vessel lumen to locate and anchor the collagen plug. The use of such fasteners, however, can cause other complications, such as thrombosis, embolization, and the like.
A more effective approach has been proposed in co- pending applications Serial No. 07/989,611; Serial No. 08/148,089; and PCT/US93/11864. A suture applying device is introduced through the tissue tract with its distal end located at the vascular puncture. One or more needles on the device are used to draw a suture through the blood vessel wall
on opposite sides of the puncture, and the suture is secured directly over the adventitial surface of the blood vessel wall to provide highly reliable closure. While a significant improvement over the use of manual pressure, clamps, and collagen plugs, in rare cases there can still be blood leakage through the sutured vascular puncture, particularly when the patient has been heavily treated with anticoagulants. Moreover, it is desirable to be able to tightly cinch the suture loops which are formed to assure complete closure of the puncture.
For these reasons, it would be desirable to provide improved methods and devices for effecting and enhancing hemostasis at vascular puncture sites after vascular catheterization procedures. In particular, it would be desirable to provide improved methods and devices for stopping bleeding at vascular puncture sites which have been sutured as a primary means of closure. It would be further desirable if such methods and devices could also serve as a primary means for effecting hemostasis, without prior suturing or other closure procedures. It would be even further desirable if such methods and devices could also be used for advancing and tightening suture knots which are formed directly over the adventitial surface of the blood vessel wall.
2. Description of the Background Art
A device and method for placing an inflatable balloon over a vascular puncture site and applying laser energy to thermally weld the artery are described in U.S. Patent No. 4,929,246. Hemostatic closure devices which place a collagen plug and polymer anchor on the adventitial and luminal surfaces of a blood vessel at a puncture site are described in a brochure of the Kensey Nash Corporation entitled The Hemostatic Puncture Close Device (undated) . Vessel closure devices employing collagen and other plugs are described in U.S. Patent Nos. 5,222,974; 5,192,302; 5,108,421; 5,061,274; 5,021,059; 4,890,612; and 4,744,364. A three part hemostasis device for introducing a collagen plug over a vascular puncture site is described in Merino et al., A
Vascular Hemostasis Device for Percutaneous Interventional Procedures , Mount Sinai Medical Center, New York, New York (undated) and Ernst et al., Immediate Sealing of Arterial Puncture Sites after Catheterization and PTCA Using a Vascular Hemostasis Device With Collagen: An International Registry, (undated) . Knot pushers, appliers, and related suturing devices are described in U.S. Patent Nos. 5,176,691; 5,201,744; 5,250,054; 4,803,984; 2,595,086; 2,131,321; 1,940,351; and 1,574,362. Co-pending applications having Serial Nos.
07/989,611, 08/148,089, and PCT/US93/11864, describe methods and apparatus for suturing vascular punctures.
SUMMARY OF THE INVENTION The present invention provides methods and devices for engaging and applying pressure directly to the adventitial surface of a blood vessel wall in the region of a vascular puncture in order to effect or enhance hemostasis. The adventitial surface is the outer most covering of the blood vessel, also referred to as the tunica adventitia in the case of arteries. By "direct" application of pressure, it is meant that a surface or other pressure-applying means is contacted directly against the adventitial surface at the distal end of a percutaneous tissue tract which has been formed as part of the vascular puncture. As explained above, most prior methods for effecting hemostasis relied on the indirect application of pressure to the puncture site by manually pressing or clamping the patient's skin over the vascular puncture. Application of pressure to the skin and subcutaneous tissue overlying the puncture is less effective in providing hemostasis, more uncomfortable to the patient, and has the other problems discussed above. Moreover, it has been found that the direct application of pressure can achieve hemostasis without the need to apply heat, as has been proposed by others. The present invention preferably relies on contacting an annular surface, usually a flat or slightly convex surface having a circular or elliptical periphery, over suture and/or a guidewire extending from the puncture through
the tissue tract and directly against the adventitial surface of the blood vessel wall. In a first aspect of the present invention, the surface can by itself provide hemostasis sufficient to permit clotting and the initial stages of healing of the vascular puncture. For example, the annular surface can be introduced over the guide wire which is left in place until the patient's condition appears to have stabilized sufficiently to withdraw the guide wire and subsequently the annular surface. It has been found that the direct application of pressure with the annular surface allows clotting and provides hemostasis even without the application of heat, as proposed in U.S. Patent 4,929,246.
In another aspect, the method of the present invention is used in combination with other procedures for providing hemostasis. In a first particular embodiment, the method provides for contacting the annular surface against a vascular puncture site which has been previously sutured to effect primary closure. Preferably, the annular surface will be introduced over the free ends of the suture in order to inhibit or stop residual bleeding which might occur in rare cases even after the primary suture loop(s) have been tied and tightened. The annular surface can also be used in conjunction with the application of tissue glues, such as those including fibrinogen, thrombin, and the like. In all cases, it is possible to secure the surface within the tissue tract so that manual retention of the surface is not necessary.
The method of the present invention will apply sufficient force over a predetermined area (i.e., pressure) to effect hemostasis at the vascular puncture site. Preferably, a force in the range from about 5 g to 50 g will be applied over an area in the range from about 6 mm2 to 30 mm2. The resulting pressures are typically applied for a period from about 10 minutes to 24 hours in order to effect hemostasis. A device according to the present invention comprises a shaft having a proximal end, a distal end, and an annular surface at its distal end. The surface will generally have a circular or elliptical periphery and will span an area
in the range from 6 mm2 to 30 mm2. The surface will be oriented at an angle from about 30° to 60° relative to the axis of the shaft. It will be appreciated that the tissue tract into the femoral artery formed by the Seldinger technique typically lies at an angle from about 30° to 60° relative to the arterial axis. The angle of the annular surface relative to the shaft is thus selected to permit introduction of the shaft through the tissue tract and positioning of the annular surface so that it lies flat over the adventitial surface of the blood vessel wall.
In a preferred aspect of the device, an axial channel or lumen is provided in the shaft to receive the suture or guide wire and facilitate anchoring the suture or guidewire to the proximal end of the device to hold the device in place.
In an optional aspect of the present invention, a pair of circumferentially spaced-apart apertures or slots are formed at the edges of the annular surface or a proximal surface to receive free suture ends for use of the device on punctures which have been previously sutured. The apertures or slots permit the device to be used as a knot pusher for advancing and tightening knots which are tied outside the tissue tract.
In the exemplary device, the shaft is cylinder and the annular surface is formed as a planar section through the cylinder at the preferred angle. The cylinder typically has a diameter from 2 mm to 10 mm and a length from about 7 cm to 12 cm.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a perspective view of a blood vessel puncture occlusion device constructed in accordance with the principles of the present invention.
Fig. 2 is a perspective view of the device of Fig. 1, taken from a bottom perspective.
Fig. 3 is a top plan view of the device of Fig. 1.
Fig. 4 is a side cross-sectional view of the device of Fig. 2.
Fig. 5 illustrates a simplified device constructed in accordance with the principles of the present invention.
Fig. 6 is a right end view of the device of Fig. 5.
Fig. 7 is a perspective view of an alternative embodiment of the blood vessel puncture occlusion device of the present invention.
Fig. 8 is a distal end view of the device of Fig. 7.
Fig. 9 is a proximal end view of the device of Fig. 7. Fig. 10 is a side view of the device of Fig. 7 shown in partial section.
Fig. 11 is a perspective view of another alternative embodiment of the blood vessel puncture occlusion device of the present invention. Fig. 12 is a side view of the device of Fig. 11 shown in partial section.
Fig. 13 illustrates an introducer sheath and guide wire which have been placed through a vascular puncture in a blood vessel by the Seldinger technique. Fig. 14 illustrates the vascular puncture as in
Fig. 7 after the introducer sheath has been withdrawn.
Fig. 15 illustrates a first method for providing hemostasis according to the present invention where pressure is applied directly in the absence of suture and a guide wire. Fig. 16 illustrates a second method for providing hemostasis according to the present invention where pressure is applied over a guide wire.
Figs. 17 and 18 illustrate a third method for providing hemostasis according to the present invention, where a suture loop is first formed and closed, and pressure applied over free ends of the suture extending from the vascular puncture site.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS Referring now to Figs. 1-4, a blood vessel puncture occlusion device 10 incorporating each of the features described in the above invention summary will be described. The device 10 comprises an elongate shaft 12 having a proximal
end 14 and an annular surface 16 at its distal end 18. An aperture or port 20 is formed generally in the center of the annular surface 16 and extends to an opening 22 (Figs. 3 and 4) at the distal end of an axial channel 24. A pair of circumferentially spaced-apart apertures or slots 26 are formed on opposite sides of the annular surface 16. An O-ring 28 circumscribes the shaft 12 near its proximal end 14 and serves to clamp or anchor suture or a guide wire which is brought through slots 26 or opening 22 into channel 24, as will be described in more detail hereinafter.
The annular surface 16 in the exemplary device 10 comprises a planar section of a cylindrical body which forms the shaft 12. The surface 16 is generally flat and formed at an angle in the range from 30° to 60° relative to the axis of shaft 12, preferably from 40° to 50°. The annular surface 16 need not be completely flat, and may in some cases be slightly convex in order to focus or center applied pressure to the puncture site in the blood vessel wall. Typically, the annular surface 16 will have an area in the range from 6 mm2 to 30 mm2, preferably from 15 mm2 to 25 mm2. In the case of convex surfaces, the center of the surface will typically be raised from the edge by distance in the range from about 0.1 mm to 1 mm. The length of the shaft 12 will typically be in the range from 7 cm to 12 cm. The cylindrical shaft 12 will usually have a uniformed diameter in the range from 2 mm to 10 mm, preferably from 6 mm to 8 mm. The occlusive surface 16 which results is thus an elliptical surface which is a section through the cylindrical shaft.
The surface 16 may be compliant or non-compliant. By "non-compliant" it is meant that the surface 16 will be able to apply pressure to the vascular puncture site without significant yield. In the embodiment of Figs. 1-4, the surface 16 is non-compliant since it is a terminal surface of solid cylindrical shaft 12, typically composed of a rigid material, such as polycarbonate, glass, ceramic, metal, or the like. In other cases, it would be possible to form the surface 16 from a compliant material, such as an elastomeric polymer, e.g., silicone rubber.
A variety of mechanisms could be provided for securing suture or a guide wire to the proximal end of the device 10. In addition to 0-ring 28 which is illustrated, suitable mechanisms include clips, adhesives, tapes, cleats, slits, latches, hooks, and other structures for securing or tying suture or a guide wire to the proximal end.
Referring now to Figs. 5 and 6, an alternative embodiment 30 of the device of the present invention is illustrated. Device 30 is simplified (in comparison to the device of Figs. 1-4) and comprises an elongate rod 32 having a finger-grasping means 34 at its proximal end and a pressure- applying surface 36 at its distal end. The surface is a circular disc, typically formed from metal, plastic, glass, ceramic, or the like, having a diameter in the range from 2 mm to 10 mm, preferably from 6 mm to 8 mm. The surface 36 will be oriented at an angle θ in the range from 30° to 60°, preferably from 40° to 50°. The length of rod 32 will typically be in the range from 7 cm to 12 cm, preferably from 8 cm to 10 cm. For use in at least some of the methods of the present invention, there is no need to provide for apertures or slots for receiving a guide wire and/or free suture ends as described in more detail hereinafter.
An alternative embodiment 100 of a blood vessel puncture occlusion device of the present invention is illustrated in Figs. 7-10. The device 100 is intended for applying pressure against the adventitial surface of a blood vessel wall surrounding a puncture site and will not be suitable for knot advancement. The device 100 comprises a shaft 102 having the dimensions generally set forth above for the embodiment of Figs. 1-4, but will be composed of a relative soft, compliant material, such as silicone rubber. An opening or gap 104 will be formed in the distal surface 106 which engages the adventitial surface of the blood vessel wall. The opening has a width and depth sufficient to receive a knot in suture, typically from 1 mm to 3 mm and 1 mm to 5 mm, respectively, and permits additional tightening or cinching on a knot in suture, where the knot is received in the opening 104 and suture passes proximally through axial
lumen 108. The ability to tighten the suture is particularly valuable when the knot has not been tied closely over the adventitial surface, i.e., an "air knot" has been inadvertently tied. The device 100 further includes slots 110 formed at the proximal end. The slots 110 facilitate tying of suture to the device to hold the device in place for extended time periods.
The device 100 will also be suitable for application of force to provide hemostasis, even when suture has not been previously placed. The device 100 can be introduced over a guidewire which passes through the tissue tract and into the blood vessel or lumen, and pressure applied until hemostasis is achieved or another procedure initiated to achieve hemostasis. Another alternative embodiment 200 of the blood vessel puncture occlusion device of the present invention is illustrated in Figs. 11 and 12. The device 200 has a first end 202 intended for applying pressure over a vascular penetration to achieve hemostasis, as generally described for previous embodiments, and a second end 204 intended for advancing knots or knot throws, also as generally described for previous embodiments.
The device 200 includes a cylindrical shaft or body 206 which is typically formed from a relative hard or rigid material, such as polycarbonate. A soft tip 208 is at the first end 202 and defines a compliant surface 210 for engaging the adventitial surface of the blood vessel. An opening or gap 212 is formed in the soft tip 208 and is connected to an axial channel 214 in the shaft 206, and an O-ring 216 is provided to anchor the device in place. Suture and/or a guidewire can be received through the opening 212 and into the channel 214 to achieve or enhance hemostasis as generally described above for the other embodiments.
Slots 220 are formed at the second end 204 to receive free suture ends and permit knot advancement. In this way, the user can select which end of the device 200 to use depending on whether hemostasis or knot advancement is the primary objective.
Referring now to Figs. 13 and 14, an introducer sheath 40 and guide wire 42 may be introduced to a blood vessel lumen BV through a tissue tract TT. The tissue tract TT extends percutaneously from the outer surface of the patient's skin S to a vascular puncture P formed through the blood vessel wall. The adventitial surface A is the exterior surface of the blood vessel wall.
The introducer sheath 40 and guide wire 42 may be used in a variety of conventional diagnostic and interventional procedures in a manner well known in the art.
At the end of such procedure(s) , it will be necessary to close and seal the vascular puncture P. According to the method of the present invention, the introducer sheath 40 will be partially or totally withdrawn, as illustrated in Fig. 14, leaving the tissue tract TT and puncture P open. It will be appreciated that the open tissue tract TT and puncture P can result in substantial blood loss after the introducer 40 has been withdrawn.
According to a first aspect of the method of the present invention, blood loss through the puncture P and tissue tract TT can be staunched by removing with guide wire 42 and introducing the device 10 through the tissue tract so that the annular surface 16 directly engages the adventitial wall A over the puncture P, as illustrated in Fig. 15. The non-compliant surface will be engaged against the adventitial surface A with a force typically in the range from 5 g to 50 g, more typically from 5 g to 25 g. Pressure may be maintained for time sufficient to permit initial blood coagulation and healing of the puncture site P. It will be appreciated that such direct application of pressure, without suturing or other means of primary closure, will generally only be useful for relatively small punctures, and for patients who have undergone little or no anti-coagulation treatment. In a second aspect of the method of the present invention, as illustrated in Fig. 16, the guide wire 42 may be left in place with the device 10 introduced thereover. The guide wire 42 will pass through aperture 20 in the non-
compliant surface 16, and upward through the channel 24. The applied force and treatment time will generally be as described above. The device 10 may optionally be held in place by securing the guide wire with 0-ring 28, or with any other securing structure which may be provided on the device 10. It will be appreciated that the guide wire 10 has a very small diameter, typically being about 0.038 inches, and that hemostasis and clotting may initiate around the guide wire, with the guide wire 42 being subsequently withdrawn. In some case, the guide wire may be withdrawn with the device 10 remaining in place with non-compliant surface 16 engaged against the puncture P.
Referring now to Figs. 17-18, a preferred method according to the present invention will be described. A primary closure of puncture P will be effected by passing a suture loop L through the blood vessel wall on opposite side of the puncture. The suture loop L is then tied-off, or otherwise secured, and the knot or other fastening structure passed down through the tissue tract to lie over the adventitial surface A. Methods and devices for forming such suture loops are well described in co-pending applications Serial No. 07/989,611, Serial No. 08/148,089, and PCT/US93/11864, the disclosures of which are incorporated herein by reference. Once the loop L has been formed, a first knot K, typically a square knot, may be pushed down the tissue tract TT using a rod or other conventional knot pusher. A particularly useful not pusher is described in copending application serial no. 08/ 252,310 , (attorney docket no. 15508-14, the disclosure of which is incorporated here in by reference) . Additional knot throws may be advanced using the device 10 by passing each of the two free suture ends through one of the slots 26 and outward through the channel 24 (Figs. 1-4) . The additional knot throws are thus advanced and tightened by tensioning the free suture ends and pushing the non-compliant surface 16 against the suture loop. The non- compliant surface 16 will at the same time apply pressure over the puncture in adventitial wall A to inhibit hemostasis.
Advice 10 may be secured by fastening the free suture ends using O-ring 28, with the device 10 being left in place for a desired amount of time to promote hemostasis and initial clot formation. It will be further appreciated that the device 10 can be used wherever it is desired to apply direct pressure to a vascular puncture through a tissue tract. It can be used, for example, if other methods for closing a vascular puncture have failed. The device can also be used in conjunction with the application of "tissue glues" at the site of the vascular puncture. Suitable tissue glues will comprise one or more components of the clotting cascade, typically comprising at least fibrinogen or thrombin, and more typically comprising both fibrinogen and thrombin. Suitable tissue glues are well described in the patent and medical literature. See, for example, U.S. Patent Nos. 4,928,603; 4,909,251; 4,427,650, the disclosures are incorporated herein by reference. The tissue glues may be introduced prior to application of pressure using the device 10 or maybe coated on the non-compliant surface and delivered to the site of vascular puncture using the device 10.
Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Claims
1. A method for occluding a blood vessel puncture at the end of a tissue tract, said method comprising: applying pressure without heat directly to the adventitial surface of the blood vessel.
2. A method as in claim 1, wherein a force in the range from 5 g to 50 g is applied over an area in the range from about 6 mm2 to 30 mm2 for a time in the range from about 10. minutes to 24 hours.
3. A method as in claim 2, wherein the pressure is applied with an annular flat surface which is engaged against the adventitial surface.
4. A method as in claim 1, further comprising applying at least one component of the clotting cascade at the puncture while applying pressure.
5. A method as in claim 4, wherein at least one of fibrinogen and thrombin is applied.
6. A method for occluding a blood vessel puncture at the end of a tissue tract, said method comprising: contacting a surface against the adventitial surface of the blood vessel over the puncture with sufficient pressure to substantially inhibit blood flow through the puncture, wherein the surface lies substantially flat over the adventitial surface while pressure is being applied.
7. A method as in claim 6, wherein a force in the range from 5 g to 50 g is applied over an area in the range from about 6 mm2 to 30 mm2 for a time in the range from about 10 minutes to 24 hours.
8. A method as in claim 6, wherein the surface is an annular surface which is introduced over suture or a guide wire extending through the tissue tract.
9. A method as in claim 6, further comprising applying at least one component of the clotting cascade at the puncture while applying pressure.
10. A method as in claim 9, wherein at least one of fibrinogen and thrombin is applied.
11. A method for occluding a blood vessel puncture at the end of a tissue tract, said method comprising: providing an occlusion device having a proximal end, a distal end and a surface at its distal end; and manually grasping the proximal end of the device, passing the distal end through the tissue tract, and contacting the surface against an adventitial surface of the blood vessel over the puncture with sufficient pressure to substantially inhibit blood flow through the puncture.
12. A method as in claim 11, wherein a force in the range from 5 g to 50 g is applied over an area in the range from about 6 mm2 to 30 mm2 for a time in the range from about 10 minutes to 24 hours.
13. A method as in claim 12, wherein a surface is introduced through the tissue tract over suture ends or a guidewire.
14. A method as in claim 11, wherein the annular surface is attached to a shaft which defines the proximal and distal ends of the device, and wherein said attachment is on an angle which is substantially equal to an angle of the tissue tract relative to the adventitial surface, and wherein the device is positioned so that said non-compliant surface lies generally flat over the adventitial surface.
15. A method as in claim 11, further comprising securing the device within the tissue tract so that said sufficient pressure is applied without manual grasping.
16. A method as in claim 11, further comprising applying at least one component of the clotting cascade at the puncture while applying pressure.
17. A method as in claim 16, wherein at least one of fibrinogen and thrombin is applied.
18. A method for closing a blood vessel puncture at the distal end of a tissue tract, said method comprising: forming a suture loop which passes through the blood vessel wall on opposite sides of the puncture with free ends of the suture passing out through the tissue tract; securing the free ends of the suture to close the puncture, and applying sufficient pressure directly to an adventitial surface of the blood vessel to inhibit blood leakage through the sutured puncture.
19. A method as in claim 21, wherein a force in the range from 5 g to 50 g is applied over an area in the range from about 6 mm2 to 30 mm2 for a time in the range from about 10 minutes to 24 hours.
20. A method as in claim 22, wherein a surface is introduced through the tissue tract over suture ends or a guidewire.
21. A method as in claim 18, wherein the non- compliant surface is attached to a shaft which is at an angle which is substantially equal to an angle of the tissue tract relative to the adventitial surface, and wherein the surface is positioned so that it lies generally flat over the adventitial surface.
22. A method as in claim 18, further comprising securing the non-compliant surface within the tissue tract so that said sufficient pressure is applied without manual grasping.
23. A method as in claim 20, wherein pressure is applied by: providing an occlusion device having a proximal end, a distal end, and the surface at its distal end; and manually grasping the proximal end of the device, passing the distal end through the tissue tract and over the free ends of the suture, and contacting the non-compliant surface against an adventitial surface of the blood vessel over the puncture with sufficient pressure to substantially inhibit blood flow through the puncture.
24. A method as in claim 18, further comprising applying at least one component of the clotting cascade at the puncture while applying pressure.
25. A method as in claim 24, wherein at least one of fibrinogen and thrombin is applied.
26. A blood vessel puncture occlusion device, said device comprising: a shaft having a proximal end, a distal end, and a surface at its distal end, wherein the surface is generally circular or elliptical, has an area in the range from 6 mm2 to 30 mm2, and is oriented at an angle from 30° to 60° relative to the axis of the shaft.
27. A device as in claim 26, wherein the shaft is a cylinder and the surface is a planar section through the cylinder at said angle.
28. A device as in claim 26, wherein the surface is annular, having an opening at its center for receiving suture or a guide wire.
29. A device as in claim 26, having a pair of circumferentially spaced-apart apertures on the surface or at a proximal end for receiving free suture ends.
30. A device as in claim 26, wherein the shaft has a length in the range from 7 cm to 12 cm.
31. A device as in claim 26, wherein at least the distal end of the shaft is composed of a soft material.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25248394A | 1994-06-01 | 1994-06-01 | |
US08/252,483 | 1994-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995032671A1 true WO1995032671A1 (en) | 1995-12-07 |
Family
ID=22956199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/006897 WO1995032671A1 (en) | 1994-06-01 | 1995-05-30 | Method and device for providing vascular hemostasis |
Country Status (2)
Country | Link |
---|---|
US (2) | US5746755A (en) |
WO (1) | WO1995032671A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5782861A (en) * | 1996-12-23 | 1998-07-21 | Sub Q Inc. | Percutaneous hemostasis device |
US5868762A (en) * | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
EP2301451A3 (en) * | 1999-09-08 | 2012-04-18 | Joseph Grayzel | Percutaneous entry system and method |
US8821918B2 (en) | 2001-03-12 | 2014-09-02 | Boston Scientific Scimed Inc. | Cross-linked gelatin composition comprising a wetting agent |
JP2016501695A (en) * | 2013-01-04 | 2016-01-21 | アンカー オーソペディックス エックスティー インコーポレイテッドAnchor Orthopedics Xt Inc. | Apparatus and method for advancing a knot |
Families Citing this family (205)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020095164A1 (en) * | 1997-06-26 | 2002-07-18 | Andreas Bernard H. | Device and method for suturing tissue |
US5827299A (en) * | 1993-08-25 | 1998-10-27 | Inlet Medical, Inc | Insertable suture passing grasping probe and methodology for using same |
JP2001522270A (en) | 1997-03-27 | 2001-11-13 | ブリストル−マイヤーズ スクイブ カンパニー | Laparoscopic sealant applicator |
US6080167A (en) * | 1998-04-28 | 2000-06-27 | Lyell; Mark S. | Anastomotic instrument |
EP1085837A4 (en) * | 1998-05-29 | 2004-06-02 | By Pass Inc | Vascular port device |
US20050283188A1 (en) * | 1998-05-29 | 2005-12-22 | By-Pass, Inc. | Vascular closure device |
US7060084B1 (en) | 1998-05-29 | 2006-06-13 | By-Pass, Inc. | Vascular closure device |
US6726704B1 (en) | 1998-05-29 | 2004-04-27 | By-Pass, Inc. | Advanced closure device |
US6048357A (en) * | 1998-07-09 | 2000-04-11 | X-Site, L.L.C. | Anchoring device and method for sealing punctures in vessels |
US7279001B2 (en) * | 1998-11-06 | 2007-10-09 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US7351249B2 (en) * | 1998-11-06 | 2008-04-01 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of suture sites |
US6080183A (en) | 1998-11-24 | 2000-06-27 | Embol-X, Inc. | Sutureless vessel plug and methods of use |
US7235087B2 (en) * | 1999-03-04 | 2007-06-26 | Abbott Park | Articulating suturing device and method |
US20040092964A1 (en) | 1999-03-04 | 2004-05-13 | Modesitt D. Bruce | Articulating suturing device and method |
US7842048B2 (en) | 2006-08-18 | 2010-11-30 | Abbott Laboratories | Articulating suture device and method |
US6964668B2 (en) * | 1999-03-04 | 2005-11-15 | Abbott Laboratories | Articulating suturing device and method |
US8137364B2 (en) | 2003-09-11 | 2012-03-20 | Abbott Laboratories | Articulating suturing device and method |
US7001400B1 (en) | 1999-03-04 | 2006-02-21 | Abbott Laboratories | Articulating suturing device and method |
US20070038231A1 (en) | 1999-05-28 | 2007-02-15 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US20060247665A1 (en) | 1999-05-28 | 2006-11-02 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
US7273497B2 (en) * | 1999-05-28 | 2007-09-25 | Anova Corp. | Methods for treating a defect in the annulus fibrosis |
US20040122456A1 (en) * | 2002-12-11 | 2004-06-24 | Saadat Vahid C. | Methods and apparatus for gastric reduction |
US7744613B2 (en) | 1999-06-25 | 2010-06-29 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US7637905B2 (en) | 2003-01-15 | 2009-12-29 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US7892246B2 (en) * | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
EP1624832A4 (en) | 1999-08-18 | 2008-12-24 | Intrinsic Therapeutics Inc | Devices and method for augmenting a vertebral disc nucleus |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
US6425919B1 (en) | 1999-08-18 | 2002-07-30 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
WO2009033100A1 (en) | 2007-09-07 | 2009-03-12 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
US6883520B2 (en) * | 1999-08-18 | 2005-04-26 | Intrinsic Therapeutics, Inc. | Methods and apparatus for dynamically stable spinal implant |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
JP4247519B2 (en) | 1999-08-18 | 2009-04-02 | イントリンジック セラピューティックス インコーポレイテッド | Apparatus and method for nucleus augmentation and retention |
WO2001015759A1 (en) * | 1999-09-01 | 2001-03-08 | Bacchus Vascular, Inc. | Methods and apparatus for accessing and treating body lumens |
US6761725B1 (en) * | 1999-09-08 | 2004-07-13 | Jeffrey Grayzel | Percutaneous entry system and method |
US7935147B2 (en) | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
US7951201B2 (en) | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7052516B2 (en) | 1999-10-20 | 2006-05-30 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and deformable spinal disc annulus stent |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US6592625B2 (en) | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US7004970B2 (en) | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US6805695B2 (en) | 2000-04-04 | 2004-10-19 | Spinalabs, Llc | Devices and methods for annular repair of intervertebral discs |
US6506178B1 (en) * | 2000-11-10 | 2003-01-14 | Vascular Architects, Inc. | Apparatus and method for crossing a position along a tubular body structure |
US7029480B2 (en) * | 2001-01-24 | 2006-04-18 | Abott Laboratories | Device and method for suturing of internal puncture sites |
US7041657B2 (en) * | 2001-02-12 | 2006-05-09 | Marine Polymer Technologies Inc. | Compositions and methods for modulation of vascular structure and/or function |
US6884249B2 (en) * | 2001-02-16 | 2005-04-26 | Depuy Mitek, Inc. | Surgical knot pusher and method of use |
US7041119B2 (en) * | 2001-02-27 | 2006-05-09 | Green David T | Apparatus for suturing a blood vessel |
US6454777B1 (en) | 2001-02-27 | 2002-09-24 | David T. Green | Apparatus and method for suturing a blood vessel |
US7204841B2 (en) * | 2001-02-27 | 2007-04-17 | Green David T | Apparatus for suturing a blood vessel |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US7892247B2 (en) | 2001-10-03 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting vessels |
US8088143B2 (en) * | 2002-06-12 | 2012-01-03 | Radi Medical Systems Ab | Closure device |
US8172856B2 (en) * | 2002-08-02 | 2012-05-08 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
US20060025788A1 (en) * | 2002-09-25 | 2006-02-02 | By-Pass, Inc. | Anastomotic leg arrangement |
US7942884B2 (en) * | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Methods for reduction of a gastric lumen |
US7942898B2 (en) * | 2002-12-11 | 2011-05-17 | Usgi Medical, Inc. | Delivery systems and methods for gastric reduction |
US20040122451A1 (en) * | 2002-12-23 | 2004-06-24 | Wood Timothy J. | Method and device for closing and fusing suture loops |
US7160309B2 (en) | 2002-12-31 | 2007-01-09 | Laveille Kao Voss | Systems for anchoring a medical device in a body lumen |
CA2511807A1 (en) * | 2002-12-31 | 2004-07-22 | Marine Polymer Technologies, Inc. | Hemostatic compositions and uses therefor |
US7223266B2 (en) | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7488340B2 (en) * | 2003-06-02 | 2009-02-10 | Vascular Solutions, Inc. | Vascular access closure system |
US9289195B2 (en) | 2003-06-04 | 2016-03-22 | Access Closure, Inc. | Auto-retraction apparatus and methods for sealing a vascular puncture |
US7331979B2 (en) * | 2003-06-04 | 2008-02-19 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
KR100828144B1 (en) | 2003-06-20 | 2008-05-14 | 인트린식 쎄라퓨틱스 인코포레이티드 | Implant for intervertebral disc annular defect |
US7462188B2 (en) | 2003-09-26 | 2008-12-09 | Abbott Laboratories | Device and method for suturing intracardiac defects |
US20050192627A1 (en) * | 2003-10-10 | 2005-09-01 | Whisenant Brian K. | Patent foramen ovale closure devices, delivery apparatus and related methods and systems |
AU2004279466A1 (en) * | 2003-10-10 | 2005-04-21 | Proximare, Inc. | Patent foramen ovale (PFO) closure devices, delivery apparatus and related methods and systems |
US7326230B2 (en) * | 2003-10-23 | 2008-02-05 | Sundaram Ravikumar | Vascular sealing device and method of use |
US8128652B2 (en) * | 2003-11-13 | 2012-03-06 | St. Jude Medical Puerto Rico Llc | Method and apparatus for sealing an internal tissue puncture incorporating a block and tackle |
ES2390273T3 (en) | 2003-11-21 | 2012-11-08 | Silk Road Medical, Inc. | Apparatus for the treatment of a carotid artery |
US7621937B2 (en) | 2003-12-03 | 2009-11-24 | St. Jude Medical Puerto Rico LC | Vascular sealing device with high surface area sealing plug |
US7597705B2 (en) | 2003-12-03 | 2009-10-06 | St. Jude Medical Puerto Rico Llc | Vascular puncture seal anchor nest |
US7347863B2 (en) | 2004-05-07 | 2008-03-25 | Usgi Medical, Inc. | Apparatus and methods for manipulating and securing tissue |
US7361180B2 (en) | 2004-05-07 | 2008-04-22 | Usgi Medical, Inc. | Apparatus for manipulating and securing tissue |
US7449024B2 (en) | 2003-12-23 | 2008-11-11 | Abbott Laboratories | Suturing device with split arm and method of suturing tissue |
US6932824B1 (en) * | 2004-03-02 | 2005-08-23 | St. Jude Medical Puerto Rico B.V. | Three-needle closure device |
US8444657B2 (en) | 2004-05-07 | 2013-05-21 | Usgi Medical, Inc. | Apparatus and methods for rapid deployment of tissue anchors |
US8257394B2 (en) | 2004-05-07 | 2012-09-04 | Usgi Medical, Inc. | Apparatus and methods for positioning and securing anchors |
US20050251205A1 (en) | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | Apparatus and methods for positioning and securing anchors |
US20050267520A1 (en) | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US7736379B2 (en) * | 2004-06-09 | 2010-06-15 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
US7695493B2 (en) * | 2004-06-09 | 2010-04-13 | Usgi Medical, Inc. | System for optimizing anchoring force |
US8206417B2 (en) * | 2004-06-09 | 2012-06-26 | Usgi Medical Inc. | Apparatus and methods for optimizing anchoring force |
US7678135B2 (en) * | 2004-06-09 | 2010-03-16 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
US7678133B2 (en) * | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
US8992549B2 (en) | 2004-08-05 | 2015-03-31 | Teleflex Medical Incorporated | Laparoscopic port site closure tool |
DE602005010442D1 (en) * | 2004-08-16 | 2008-11-27 | Zimmer Spine Inc | SPIRAL SEWING DEVICE |
US20060058844A1 (en) * | 2004-09-13 | 2006-03-16 | St. Jude Medical Puerto Rico B.V. | Vascular sealing device with locking system |
US20090326578A1 (en) * | 2004-09-30 | 2009-12-31 | Usgi Medical, Inc. | Interlocking tissue anchor apparatus and methods |
WO2006054170A1 (en) | 2004-11-22 | 2006-05-26 | Cardiodex Ltd. | Techniques for heat-treating varicose veins |
US8109945B2 (en) * | 2005-02-04 | 2012-02-07 | St. Jude Medical Puerto Rico Llc | Percutaneous suture path tracking device with cutting blade |
US7618436B2 (en) * | 2005-04-12 | 2009-11-17 | St. Jude Medical Puerto Rico Llc | Tissue puncture closure device with scroll gear transmission tamping system |
AU2006247355B2 (en) | 2005-05-12 | 2013-01-10 | Arstasis, Inc. | Access and closure device and method |
US8038687B2 (en) * | 2005-05-17 | 2011-10-18 | St. Jude Medical Puerto Rico Llc | Suture loop closure device |
US9585651B2 (en) | 2005-05-26 | 2017-03-07 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
US8298291B2 (en) | 2005-05-26 | 2012-10-30 | Usgi Medical, Inc. | Methods and apparatus for securing and deploying tissue anchors |
US20070010855A1 (en) * | 2005-07-05 | 2007-01-11 | Florez Mendez Maximiliano E | Facial lifting needle and method thereof |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
WO2007019016A1 (en) | 2005-08-08 | 2007-02-15 | Abbott Laboratories | Vascular suturing device |
US8083754B2 (en) | 2005-08-08 | 2011-12-27 | Abbott Laboratories | Vascular suturing device with needle capture |
US7883517B2 (en) | 2005-08-08 | 2011-02-08 | Abbott Laboratories | Vascular suturing device |
US8920442B2 (en) | 2005-08-24 | 2014-12-30 | Abbott Vascular Inc. | Vascular opening edge eversion methods and apparatuses |
US9456811B2 (en) | 2005-08-24 | 2016-10-04 | Abbott Vascular Inc. | Vascular closure methods and apparatuses |
US20070060895A1 (en) | 2005-08-24 | 2007-03-15 | Sibbitt Wilmer L Jr | Vascular closure methods and apparatuses |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
WO2007038336A2 (en) * | 2005-09-23 | 2007-04-05 | Ellipse Technologies, Inc. | Method and apparatus for adjusting body lumens |
US20070123934A1 (en) * | 2005-09-26 | 2007-05-31 | Whisenant Brian K | Delivery system for patent foramen ovale closure device |
US8382794B2 (en) * | 2006-01-04 | 2013-02-26 | St. Jude Medical Puerto Rico Llc | Balloon insertion apparatus and method of sealing a tissue puncture |
US8726909B2 (en) | 2006-01-27 | 2014-05-20 | Usgi Medical, Inc. | Methods and apparatus for revision of obesity procedures |
US8764835B2 (en) * | 2006-06-13 | 2014-07-01 | Bret A. Ferree | Intervertebral disc treatment methods and apparatus |
US8821549B2 (en) | 2006-06-13 | 2014-09-02 | Anova Corporation | Methods and apparatus for anulus repair |
US8834496B2 (en) | 2006-06-13 | 2014-09-16 | Bret A. Ferree | Soft tissue repair methods and apparatus |
US9232938B2 (en) | 2006-06-13 | 2016-01-12 | Anova Corp. | Method and apparatus for closing fissures in the annulus fibrosus |
US8870916B2 (en) | 2006-07-07 | 2014-10-28 | USGI Medical, Inc | Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use |
US7749248B2 (en) | 2006-09-18 | 2010-07-06 | St. Jude Medical Puerto Rico Llc | Flexible tamping device |
CN101715329B (en) | 2007-03-05 | 2012-11-14 | 恩多斯潘有限公司 | Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same |
US20090036923A1 (en) * | 2007-05-04 | 2009-02-05 | Jabba Ronald J | Systems and methods for accommodating anatomical characteristics in the treatment of septal defects |
US8574244B2 (en) | 2007-06-25 | 2013-11-05 | Abbott Laboratories | System for closing a puncture in a vessel wall |
US20100228269A1 (en) * | 2009-02-27 | 2010-09-09 | Garrison Michi E | Vessel closure clip device |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
ES2913223T3 (en) | 2007-07-18 | 2022-06-01 | Silk Road Medical Inc | Systems for establishing retrograde carotid arterial blood flow |
US9282967B2 (en) | 2007-08-02 | 2016-03-15 | Bioconnect Systems, Inc. | Implantable flow connector |
WO2009020941A1 (en) | 2007-08-02 | 2009-02-12 | Bio Connect Systems | Implantable flow connector |
EP2182875A4 (en) * | 2007-08-15 | 2011-08-24 | Cardiodex Ltd | Systems and methods for puncture closure |
US8568445B2 (en) * | 2007-08-21 | 2013-10-29 | St. Jude Medical Puerto Rico Llc | Extra-vascular sealing device and method |
US8333787B2 (en) | 2007-12-31 | 2012-12-18 | St. Jude Medical Puerto Rico Llc | Vascular closure device having a flowable sealing material |
CN101965162B (en) | 2007-12-15 | 2014-12-10 | 恩多斯潘有限公司 | Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof |
US9282953B2 (en) * | 2007-12-31 | 2016-03-15 | St. Jude Medical Puerto Rico Llc | Systems and methods for locating and closing a tissue puncture |
US8840640B2 (en) | 2007-12-31 | 2014-09-23 | St. Jude Medical Puerto Rico Llc | Vascular closure device having an improved plug |
ES2821762T3 (en) | 2008-02-05 | 2021-04-27 | Silk Road Medical Inc | Interventional catheter system |
US8029533B2 (en) | 2008-04-04 | 2011-10-04 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US9364206B2 (en) | 2008-04-04 | 2016-06-14 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
WO2010011696A1 (en) * | 2008-07-21 | 2010-01-28 | Arstasis, Inc. | Devices and methods for forming tracts in tissue |
WO2010011695A1 (en) | 2008-07-21 | 2010-01-28 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
EP2306886B1 (en) * | 2008-07-30 | 2018-10-31 | Acclarent, Inc. | Paranasal ostium finder devices |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
JP2012500049A (en) * | 2008-08-13 | 2012-01-05 | シルク・ロード・メディカル・インコーポレイテッド | Suture delivery device |
WO2010027693A2 (en) | 2008-08-26 | 2010-03-11 | Killion Douglas P | Method and system for sealing percutaneous punctures |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US20100168770A1 (en) * | 2008-12-30 | 2010-07-01 | Richard S. Wilkenfeld | Laparoscopic method for suturing in a body cavity |
US20100168769A1 (en) * | 2008-12-30 | 2010-07-01 | Richard S. Wilkenfeld | Laparoscopic knot pushing device |
JP5720031B2 (en) | 2009-01-12 | 2015-05-20 | テレフレックス メディカル インコーポレイテッドTeleflex Medical Incorporated | Apparatus and method for tissue closure |
WO2010150208A2 (en) | 2009-06-23 | 2010-12-29 | Endospan Ltd. | Vascular prostheses for treating aneurysms |
WO2011004374A1 (en) | 2009-07-09 | 2011-01-13 | Endospan Ltd. | Apparatus for closure of a lumen and methods of using the same |
US8252022B2 (en) * | 2009-07-13 | 2012-08-28 | Vascular Solutions, Inc. | Metal vascular aperture closure device |
EP3735937A1 (en) | 2009-11-30 | 2020-11-11 | Endospan Ltd. | Multi-component stent-graft system for implantation in a blood vessel with multiple branches |
EP2509535B1 (en) | 2009-12-08 | 2016-12-07 | Endospan Ltd | Endovascular stent-graft system with fenestrated and crossing stent-grafts |
EP2519166A4 (en) | 2009-12-31 | 2017-06-14 | Endospan Ltd | Endovascular flow direction indicator |
US8460319B2 (en) | 2010-01-11 | 2013-06-11 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and method |
US9468517B2 (en) | 2010-02-08 | 2016-10-18 | Endospan Ltd. | Thermal energy application for prevention and management of endoleaks in stent-grafts |
US9370353B2 (en) | 2010-09-01 | 2016-06-21 | Abbott Cardiovascular Systems, Inc. | Suturing devices and methods |
US8663252B2 (en) | 2010-09-01 | 2014-03-04 | Abbott Cardiovascular Systems, Inc. | Suturing devices and methods |
US20120191128A1 (en) | 2011-01-25 | 2012-07-26 | Wound Care 360?, Inc. | Vascular wound closing apparatus and method |
EP2579810A4 (en) | 2011-02-03 | 2014-07-30 | Endospan Ltd | Implantable medical devices constructed of shape memory material |
US9855046B2 (en) | 2011-02-17 | 2018-01-02 | Endospan Ltd. | Vascular bands and delivery systems therefor |
WO2012117395A1 (en) | 2011-03-02 | 2012-09-07 | Endospan Ltd. | Reduced-strain extra- vascular ring for treating aortic aneurysm |
US9386968B2 (en) | 2011-05-11 | 2016-07-12 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8574287B2 (en) | 2011-06-14 | 2013-11-05 | Endospan Ltd. | Stents incorporating a plurality of strain-distribution locations |
EP2579811B1 (en) | 2011-06-21 | 2016-03-16 | Endospan Ltd | Endovascular system with circumferentially-overlapping stent-grafts |
WO2013005207A1 (en) | 2011-07-07 | 2013-01-10 | Endospan Ltd. | Stent fixation with reduced plastic deformation |
WO2013030818A2 (en) | 2011-08-28 | 2013-03-07 | Endospan Ltd. | Stent-grafts with post-deployment variable axial and radial displacement |
WO2013065040A1 (en) | 2011-10-30 | 2013-05-10 | Endospan Ltd. | Triple-collar stent-graft |
WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
WO2013103682A2 (en) | 2012-01-04 | 2013-07-11 | Teleflex Medical Incorporated | Apparatus and methods for tissue closure |
US8864778B2 (en) | 2012-04-10 | 2014-10-21 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
US8858573B2 (en) | 2012-04-10 | 2014-10-14 | Abbott Cardiovascular Systems, Inc. | Apparatus and method for suturing body lumens |
US9314600B2 (en) | 2012-04-15 | 2016-04-19 | Bioconnect Systems, Inc. | Delivery system for implantable flow connector |
US10434293B2 (en) | 2012-04-15 | 2019-10-08 | Tva Medical, Inc. | Implantable flow connector |
US9265514B2 (en) | 2012-04-17 | 2016-02-23 | Miteas Ltd. | Manipulator for grasping tissue |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
US20130317438A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US20130317481A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US9241707B2 (en) | 2012-05-31 | 2016-01-26 | Abbott Cardiovascular Systems, Inc. | Systems, methods, and devices for closing holes in body lumens |
US9259212B2 (en) | 2012-07-24 | 2016-02-16 | Wound Care 360, LLC | Vascular wound closing apparatus and method |
WO2014025930A1 (en) | 2012-08-09 | 2014-02-13 | Silk Road Medical, Inc. | Suture delivery device |
US8915933B2 (en) | 2012-11-02 | 2014-12-23 | Medtronic Vascular, Inc. | Suturing device having a retractable distal tip and method for sealing an opening in a blood vessel or other biological structure |
WO2014108895A2 (en) | 2013-01-08 | 2014-07-17 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
US9655754B2 (en) * | 2013-01-10 | 2017-05-23 | Trivascular, Inc. | Systems and methods for guidewire crossover for bifurcated prostheses |
US20140194970A1 (en) * | 2013-01-10 | 2014-07-10 | Trivascular, Inc. | Gate wire for contralateral leg access |
WO2014117107A1 (en) | 2013-01-28 | 2014-07-31 | Cartiva, Inc. | Systems and methods for orthopedic repair |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
WO2014138284A1 (en) | 2013-03-07 | 2014-09-12 | Cedars-Sinai Medical Center | Catheter based apical approach heart prostheses delivery system |
US10105221B2 (en) | 2013-03-07 | 2018-10-23 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiovascular prosthesis |
US9668892B2 (en) | 2013-03-11 | 2017-06-06 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
US9364208B2 (en) | 2014-03-18 | 2016-06-14 | King Abdullah International Medical Research Center | Medical material delivery device |
US10182801B2 (en) | 2014-05-16 | 2019-01-22 | Silk Road Medical, Inc. | Vessel access and closure assist system and method |
WO2016040526A1 (en) | 2014-09-10 | 2016-03-17 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiac valve prosthesis |
US10758265B2 (en) | 2014-11-14 | 2020-09-01 | Cedars-Sinai Medical Center | Cardiovascular access and device delivery system |
WO2016098113A1 (en) | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
EP3324855B1 (en) | 2015-07-23 | 2024-03-20 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US11439501B2 (en) | 2017-01-25 | 2022-09-13 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US10426449B2 (en) | 2017-02-16 | 2019-10-01 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device with improved actuation and alignment mechanisms |
US11291544B2 (en) | 2018-02-02 | 2022-04-05 | Cedars-Sinai Medical Center | Delivery platforms, devices, and methods for tricuspid valve repair |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610248A (en) * | 1984-09-18 | 1986-09-09 | University Of Medicine And Dentistry Of New Jersey | Surgical finger assembly |
US5129882A (en) * | 1990-12-27 | 1992-07-14 | Novoste Corporation | Wound clotting device and method of using same |
US5176691A (en) * | 1990-09-11 | 1993-01-05 | Pierce Instruments, Inc. | Knot pusher |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1574362A (en) * | 1922-09-23 | 1926-02-23 | Isabel G Callahan | Hemostatic forceps |
US1940351A (en) * | 1933-03-22 | 1933-12-19 | Dougald T Mckinnon | Surgical instrument |
US2131321A (en) * | 1937-10-11 | 1938-09-27 | Hart Wilber | Ligator |
US2595086A (en) * | 1948-11-30 | 1952-04-29 | Henry B Larzelere | Surgical instrument |
JPS6144825A (en) * | 1984-08-09 | 1986-03-04 | Unitika Ltd | Hemostatic agent |
US4744364A (en) * | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US4852568A (en) * | 1987-02-17 | 1989-08-01 | Kensey Nash Corporation | Method and apparatus for sealing an opening in tissue of a living being |
US4890612A (en) * | 1987-02-17 | 1990-01-02 | Kensey Nash Corporation | Device for sealing percutaneous puncture in a vessel |
US4803984A (en) * | 1987-07-06 | 1989-02-14 | Montefiore Hospital Association Of Western Pennsylvania | Method for performing small vessel anastomosis |
US4929246A (en) * | 1988-10-27 | 1990-05-29 | C. R. Bard, Inc. | Method for closing and sealing an artery after removing a catheter |
US5061274A (en) * | 1989-12-04 | 1991-10-29 | Kensey Nash Corporation | Plug device for sealing openings and method of use |
JP2528602B2 (en) * | 1989-12-04 | 1996-08-28 | ケンゼー・ナッシュ・コーポレーション | Plug device for sealing the opening |
US5163946A (en) * | 1990-04-25 | 1992-11-17 | Mitek Surgical Products, Inc. | Suture rundown tool and cutter system |
US5021059A (en) * | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5108421A (en) * | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5419765A (en) * | 1990-12-27 | 1995-05-30 | Novoste Corporation | Wound treating device and method for treating wounds |
US5320629B1 (en) * | 1991-01-07 | 2000-05-02 | Advanced Surgical Inc | Device and method for applying suture |
AU662357B2 (en) * | 1991-10-18 | 1995-08-31 | Ethicon Inc. | Adhesion barrier applicator |
US5290310A (en) * | 1991-10-30 | 1994-03-01 | Howmedica, Inc. | Hemostatic implant introducer |
US5222974A (en) * | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5201744A (en) * | 1991-12-05 | 1993-04-13 | Jones Mark W | Method and device for suturing using a rod with a needle holder |
CA2134071C (en) * | 1992-04-23 | 1999-04-27 | Sew Wah Tay | Apparatus and method for sealing vascular punctures |
US5250054A (en) * | 1992-05-01 | 1993-10-05 | Li Medical Technologies, Inc. | Intracorporeal knot tying apparatus and method |
US5292332A (en) * | 1992-07-27 | 1994-03-08 | Lee Benjamin I | Methods and device for percutanceous sealing of arterial puncture sites |
US5254113A (en) * | 1992-08-31 | 1993-10-19 | Wilk Peter J | Anastomosis method |
US5624446A (en) * | 1992-09-11 | 1997-04-29 | University Of Washington | System for repair of capsulo-labral separations |
US5330491A (en) * | 1992-09-18 | 1994-07-19 | Ethicon, Inc. | Endoscopic suturing device |
US5234445A (en) * | 1992-09-18 | 1993-08-10 | Ethicon, Inc. | Endoscopic suturing device |
US5292327A (en) * | 1992-10-08 | 1994-03-08 | Dodd Joseph T | Surgical knot pusher |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5397326A (en) * | 1993-04-15 | 1995-03-14 | Mangum; William K. | Knot pusher for videoendoscopic surgery |
US5462561A (en) * | 1993-08-05 | 1995-10-31 | Voda; Jan K. | Suture device |
US5462560A (en) * | 1993-10-08 | 1995-10-31 | Tahoe Surgical Instruments | Double needle ligature device |
US5722981A (en) * | 1993-10-08 | 1998-03-03 | Tahoe Surgical Instruments | Double needle ligature device |
CA2176826C (en) * | 1993-12-10 | 2000-09-26 | Nusayr Azam | Guiding catheter |
US5562684A (en) * | 1994-10-11 | 1996-10-08 | Ethicon, Inc. | Surgical knot pusher device and improved method of forming knots |
-
1995
- 1995-05-30 WO PCT/US1995/006897 patent/WO1995032671A1/en active Application Filing
- 1995-11-15 US US08/559,254 patent/US5746755A/en not_active Expired - Lifetime
-
1997
- 1997-10-16 US US08/951,985 patent/US6117145A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610248A (en) * | 1984-09-18 | 1986-09-09 | University Of Medicine And Dentistry Of New Jersey | Surgical finger assembly |
US5176691A (en) * | 1990-09-11 | 1993-01-05 | Pierce Instruments, Inc. | Knot pusher |
US5129882A (en) * | 1990-12-27 | 1992-07-14 | Novoste Corporation | Wound clotting device and method of using same |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5782861A (en) * | 1996-12-23 | 1998-07-21 | Sub Q Inc. | Percutaneous hemostasis device |
US5868762A (en) * | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
EP2301451A3 (en) * | 1999-09-08 | 2012-04-18 | Joseph Grayzel | Percutaneous entry system and method |
US8821918B2 (en) | 2001-03-12 | 2014-09-02 | Boston Scientific Scimed Inc. | Cross-linked gelatin composition comprising a wetting agent |
JP2016501695A (en) * | 2013-01-04 | 2016-01-21 | アンカー オーソペディックス エックスティー インコーポレイテッドAnchor Orthopedics Xt Inc. | Apparatus and method for advancing a knot |
EP2941197A4 (en) * | 2013-01-04 | 2016-09-07 | Anchor Orthopedics Xt Inc | Devices and methods for advancing knots |
US10849612B2 (en) | 2013-01-04 | 2020-12-01 | Anchor Orthopedics Xt. Inc. | Devices and methods for advancing knots |
EP3760134A1 (en) * | 2013-01-04 | 2021-01-06 | Anchor Orthopedics XT Inc. | A knot pusher |
Also Published As
Publication number | Publication date |
---|---|
US6117145A (en) | 2000-09-12 |
US5746755A (en) | 1998-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5746755A (en) | Method and device for providing hemostasis at vascular penetration sites | |
US20210290219A1 (en) | Vascular hole closure delivery device | |
EP0910288B1 (en) | Low profile intraluminal suturing device | |
US9320505B2 (en) | Apparatus for closing vascular puncture | |
EP1526810B1 (en) | Apparatus for sealing surgical punctures | |
US7445626B2 (en) | Device and method for suturing tissue | |
US7901428B2 (en) | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use | |
US10327760B2 (en) | Sizing and positioning adapter for medical instruments | |
US10390807B2 (en) | Vascular hole closure device | |
US20080287967A1 (en) | Device and Methods for Suturing Tissue | |
JP2003518975A (en) | Device for closing tissue punctures | |
JP2012192193A (en) | System for closing vessel wound | |
US9533076B2 (en) | Carriers for hemostatic tract treatment | |
US20090270911A1 (en) | Vessel Sealing Device and Method of Using Same | |
EP3104785B1 (en) | Apparatus for forming a suture connector in situ | |
US8740938B2 (en) | System, method, and device for closing an opening | |
Meucci et al. | The Essentials of Femoral Vascular Access and Closure | |
Feldman et al. | The Essentials of Femoral Vascular Access and Closure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase |